# Benitec Biopharma Inc.: Form SCHEDULE 13D/A, filed Mar 28, 2025

- Company: [Benitec Biopharma Inc.](/companies/bntc.md) (CIK 1808898)
- Form: SCHEDULE 13D/A
- Filed: 2025-03-28
- Accepted by EDGAR: Mar 28, 2025, 16:50 ET
- Period: not reported
- Accession: 0000899140-25-000478
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1808898/000089914025000478/xslSCHEDULE_13D_X01/primary_doc.xml
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1808898/000089914025000478/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1808898/000089914025000478/xslSCHEDULE_13D_X01/primary_doc.xml

Filed Mar 28, 2025.
Source: SEC EDGAR, the filing index for accession 0000899140-25-000478. Last ingested by Listed: Oct 28, 2026, 08:04 ET. No prices; not investment advice.